This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. Its structure, featuring a fluorophenyl group and a cyclobutane ring, makes it a valuable intermediate in the creation of compounds targeting central nervous system disorders. Researchers explore its potential in designing drugs for conditions such as depression, anxiety, and other neurological diseases due to its ability to interact with specific receptors in the brain. Additionally, it may be employed in the study of enzyme inhibition or as a building block in medicinal chemistry to optimize drug efficacy and selectivity.